Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Miguel Álvarez-Montero
Observed name:
Miguel Álvarez Montero
Institutions:
Hospital Universitario La Paz,
Hospital La Paz Institute for Health Research,
Universidad Autónoma de Madrid
Observed institutions:
Hospital Universitario La Paz,
Hospital La Paz Institute for Health Research,
Universidad Autónoma de Madrid
ORCID:
0009-0002-4896-1815
Observed ORCID:
0009-0002-4896-1815
OpenAlex ID:
A5120589966
Diagnostic performance of lymphocyte transformation test and flow cytometry in the identification of culprit drugs in organ-specific serious adverse drug reactions
2025
·
Carmen Ruiz-Fernández
, Ibtissam Akatbach-Bousaid
, et al.
·
Diagnosis
·
2
PDF
Incomplete linkage disequilibrium between DPYD HapB3 variants: implications for pharmacogenetic phenotype assignment
2026
·
Miguel Álvarez-Montero
, Fiorela C. Dueñas-López
, et al.
·
Frontiers in Pharmacology
PDF
Age-related patterns in paediatric paracetamol poisoning: a retrospective cohort study, 2015–2025
2026
·
Miguel Álvarez-Montero
, Fiorela Dueñas-López
, et al.
·
Clinical Toxicology
PDF
The ESINEA Study: A Novel Screening Tool for Identifying Patient Safety Incidents and Adverse Events in Hospitalized Patients–An Index-Date Cohort Evaluation
2026
·
Fiorela Dueñas Lopez
, Alba Fernández-Arroyo García
, et al.
·
Therapeutics and Clinical Risk Management
PDF
Impact of lymphocyte transformation test on the diagnostic accuracy of the culprit drug in drug-induced cytopenias: a case-control study
2025
·
Susana Martín-López
, Olga Rogozina
, et al.
·
Frontiers in Pharmacology
PDF
Show more works
View as search
Works count:
5
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type